Blood 'fingerprints' for cancer

Sep 03, 2008

Serum microRNAs (miRNAs) can serve as biomarkers for the detection of diseases including cancer and diabetes, according to research published online this week in Cell Research. The findings pave the way for a revolutionary non-invasive diagnostic tool.

miRNAs are a class of naturally occurring small non-coding RNAs that have been linked with cancer development. Recent studies reporting individual miRNAs as diagnostic biomarkers of specific cancers were unable to rule out the possibility that these miRNAs appeared as a result of contamination.

Chen-Yu Zhang and colleagues are the first to comprehensively characterize entire blood miRNA profiles of healthy subjects and patients with lung cancer, colorectal cancer and diabetes, ruling out contamination. They propose that the specific serum miRNA expression profiles they identified constitute ‘fingerprints’ for cancer and disease.

Although tumour markers greatly improve diagnosis, current diagnostic techniques are prohibitively invasive and therefore have limited clinical application. The new approach is non-invasive and has the potential to transform the clinical management of various cancers and diseases through improving disease diagnosis, cancer classification, prognosis estimation, prediction of therapeutic efficacy, maintenance of surveillance following surgery, and the ability to forecast disease recurrence. The new technique will also be useful to pharmacological companies in identifying population subgroups who are responsive to drugs that have failed in phase III clinical trials.

Source: Nanjing University School of Life Sciences

Explore further: Adults with intellectual and developmental disabilities are much less likely to be screened for colorectal cancer

add to favorites email to friend print save as pdf

Related Stories

French minister meets with Google, Facebook, Twitter

7 hours ago

The French interior minister is meeting with representatives from Google, Facebook and Twitter to encourage them to join the European Union in its fight against propaganda disseminated online by terrorist ...

Ancient and modern cities aren't so different

7 hours ago

Despite notable differences in appearance and governance, ancient human settlements function in much the same way as modern cities, according to new findings by researchers at the Santa Fe Institute and the ...

Recommended for you

Cancer drug first tested in pet dogs begins human trials

3 hours ago

A new drug that prompts cancer cells to self-destruct while sparing healthy cells is now entering phase I clinical trials in humans. The drug, called PAC-1, first showed promise in the treatment of pet dogs ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.